Drug therapy of hypertension: What we have, what we need, what we expect
- 1 October 1974
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 34 (4) , 471-475
- https://doi.org/10.1016/0002-9149(74)90016-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- -Blockers and Plasma Renin Activity in HypertensionBMJ, 1974
- The Therapeutic Challenge of Systolic HypertensionNew England Journal of Medicine, 1973
- Minoxidil — An Alternative to Nephrectomy for Refractory HypertensionNew England Journal of Medicine, 1973
- Central nervous ?-adrenergic receptors and the mode of action of ?-methyldopaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic BlockadeNew England Journal of Medicine, 1970
- Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, catapresan)European Journal of Pharmacology, 1969
- Central hypotensive effect of α-methyldopaJournal of Pharmacy and Pharmacology, 1968
- Effects of Chlorothiazide on Systemic Hemodynamics in Essential HypertensionCirculation, 1962